1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Genetic and Imaging Characteristics of a Family With Neuronal Intranuclear Inclusion Disease

      brief-report

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Dear Editor, Neuronal intranuclear inclusion disease (NIID) is a rare slowly progressive neurodegenerative disease characterized by intranuclear inclusions in the central, peripheral, and autonomic nervous systems and visceral organ cells.1 The various reported clinical manifestations of NIID include pyramidal and extrapyramidal symptoms, dementia, neuropathy, and autonomic dysfunction.1 We present the first case of genetically confirmed familial NIID in Korea, including MRI findings from its early stages. A 56-year-old female (Patient 1) experienced recurrent vomiting and dizziness approximately once yearly, recovering spontaneously within a couple of days. At 61 years of age she lost consciousness every few months, recovering without complications within 24 hours. At 62 years of age she was referred to our neurology department due to a stuporous mental state lasting 9 days. Her mental state and cognition improved slowly. She could say her name at 26 days after the onset (Mini-Mental State Examination [MMSE] score=4) and showed significant improvement 3 months later (MMSE score=16). Loss of consciousness with confusion recurred twice at 62 and 67 years of age (MMSE score=2 at the attack when 67 years of age). During nonrecurrence periods between 62 and 67 years of age, she could do housework, including cooking, and perform the activities of daily living. After the last attack at 67 years of age, she showed obvious cognitive impairment and needed help from other people, but remained living in her own home with an alert mental state while consuming normal meals and walking independently (MMSE score=10, Clinical Dementia Rating=1). A younger brother of Patient 1 (Patient 2) began experiencing an episodic visual field defect at 54 years of age. At 56 years of age he began experiencing periodic nausea and vomiting lasting for several days. At 57 years of age he experienced the subacute onset of left homonymous hemianopsia, for which he visited our neurology department. His left hemianopsia disappeared after 5 months. Detailed neuropsychological tests showed global cognitive impairment (MMSE score=25). He subsequently frequently experienced nausea, vomiting, and loss of consciousness. At 58 years of age he exhibited confusion and neuropsychiatric symptoms, including occasional visual hallucinations and aggression (MMSE score=22), and repeated episodic visual field defect that alternated between the right and left sides. His ophthalmology assessment results were normal. At 61 years of age he presented with daily vigorous vomiting and loss of consciousness (MMSE=27). He died of malnutrition and sepsis at 62 years of age despite receiving supportive care. Laboratory test results revealed sensorimotor and autonomic neuropathy and neurogenic bladder in both patients. Their mother exhibited dementia symptoms at 69 years of age and their father had a stroke (Supplementary Fig. 1 in the online-only Data Supplement). We found subcortical white-matter hyperintensities (WMH) in fluid-attenuated inversion recovery (FLAIR) imaging and high-intensity signals at the corticomedullary junction in diffusion-weighted imaging (DWI) (Fig. 1A and B). A skin biopsy revealed ubiquitin-positive intranuclear inclusions in the sweat-gland cells of both patients. Electron microscopy revealed intranuclear inclusions with fine filaments in sweat-gland cells (Fig. 1C). Genetic testing performed using the method described in the Supplementary Material (in the online-only Data Supplement) revealed 149 and 107 GGC-repeat expansions in NOTCH2NLC in Patient 1 and Patient 2, respectively (disease-causing range, 41 to 300 repeats)2 (Fig. 1D). The wide variation in repeat length in Patient 2 suggests repeat instability and/or somatic mosaicism. We found that the fragile X mental retardation 1 (FMR1) permutation CGG repeats were within the normal range in Patient 2. The FMR1 gene was not analyzed for Patient 1. These two patients were diagnosed with familial adult-onset NIID based on clinical symptoms, characteristic MRI findings, intranuclear inclusions on skin biopsy, and NOTCH2NLC GGC-repeat expansions. Patient 1 experienced relatively long episodes of unconsciousness and cognitive impairment (lasting several weeks), and eventually developed dementia, whereas Patient 2 presented with stroke-like encephalopathy and recurrent short episodes of unconsciousness (lasting about 20 minutes) and vigorous vomiting. Variations in repeat length may have been responsible for the phenotypic variations. However, the length of the GGC repeats was not correlated with clinical symptoms in a previous study.3 Abnormal DWI findings in the corticomedullary junction are strongly related to NIID, appearing in 100% of sporadic cases and 81% of familial cases.1 However, in our patients, typical DWI findings appeared 2–3 years after the first symptom and presented as larger areas of high-intensity signals when WMH became extensive. We found high-intensity signals in the splenium and genu, with mild WMH in FLAIR images during the early stages. Other early findings included high-intensity signals in the splenium in DWI (Fig. 1A-1) and the cerebellar hemisphere adjacent to the vermis in FLAIR images (Fig. 1B-1). High-intensity signals in the cerebellar hemisphere adjacent to the vermis were observed previously in FLAIR images, even in the absence of DWI abnormalities.4 5 Two sporadic cases confirmed by skin biopsy were reported in Korea, with clinical manifestations including rapidly progressive dementia,6 repeated confusion, and slowly progressive cognitive impairment.7 Our patients exhibited clinical manifestations and/or abnormal findings for the central, autonomic, and peripheral nerve systems. In particular, periodic vomiting, which is considered an autonomic symptom,8 9 was one of the main symptoms in our patients. Approximately 15% of sporadic cases and 31% of familial cases present with vomiting.1 Clinicians must consider NIID in the differential diagnosis of repeated unconsciousness and vomiting even before obvious cognitive impairment or DWI abnormalities are detected.

          Related collections

          Most cited references9

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          Clinicopathological features of adult-onset neuronal intranuclear inclusion disease

          Neuronal intranuclear inclusion disease (NIID) has highly variable clinical manifestations. Sone et al. describe the clinical and pathological features of 57 adult-onset cases diagnosed by postmortem dissection/antemortem skin biopsy. They report ‘dementia dominant’ and ‘limb weakness’ subtypes, and recommend consideration of NIID in the differential diagnosis of leukoencephalopathy and neuropathy.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            CGG expansion in NOTCH2NLC is associated with oculopharyngodistal myopathy with neurological manifestations

            Oculopharyngodistal myopathy (OPDM) is a rare hereditary muscle disease characterized by progressive distal limb weakness, ptosis, ophthalmoplegia, bulbar muscle weakness and rimmed vacuoles on muscle biopsy. Recently, CGG repeat expansions in the noncoding regions of two genes, LRP12 and GIPC1, have been reported to be causative for OPDM. Furthermore, neuronal intranuclear inclusion disease (NIID) has been recently reported to be caused by CGG repeat expansions in NOTCH2NLC. We aimed to identify and to clinicopathologically characterize patients with OPDM who have CGG repeat expansions in NOTCH2NLC (OPDM_NOTCH2NLC). Note that 211 patients from 201 families, who were clinically or clinicopathologically diagnosed with OPDM or oculopharyngeal muscular dystrophy, were screened for CGG expansions in NOTCH2NLC by repeat primed-PCR. Clinical information and muscle pathology slides of identified patients with OPDM_NOTCH2NLC were re-reviewed. Intra-myonuclear inclusions were evaluated using immunohistochemistry and electron microscopy (EM). Seven Japanese OPDM patients had CGG repeat expansions in NOTCH2NLC. All seven patients clinically demonstrated ptosis, ophthalmoplegia, dysarthria and muscle weakness; they myopathologically had intra-myonuclear inclusions stained with anti-poly-ubiquitinated proteins, anti-SUMO1 and anti-p62 antibodies, which were diagnostic of NIID (typically on skin biopsy), in addition to rimmed vacuoles. The sample for EM was available only from one patient, which demonstrated intranuclear inclusions of 12.6 ± 1.6 nm in diameter. We identified seven patients with OPDM_NOTCH2NLC. Our patients had various additional central and/or peripheral nervous system involvement, although all were clinicopathologically compatible; thus, they were diagnosed as having OPDM and expanding a phenotype of the neuromyodegenerative disease caused by CGG repeat expansions in NOTCH2NLC.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Neuronal intranuclear hyaline inclusion disease showing motor-sensory and autonomic neuropathy.

              Neuronal intranuclear hyaline inclusion disease (NIHID), a rare neurodegenerative disease in which eosinophilic intranuclear inclusions develop mainly in neurons, has not yet been described to present as hereditary motor-sensory and autonomic neuropathy.
                Bookmark

                Author and article information

                Journal
                J Clin Neurol
                J Clin Neurol
                JCN
                Journal of Clinical Neurology (Seoul, Korea)
                Korean Neurological Association
                1738-6586
                2005-5013
                May 2022
                28 April 2022
                : 18
                : 3
                : 358-360
                Affiliations
                [a ]Department of Neurology, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan, Korea.
                [b ]Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Yangsan, Korea.
                [c ]Department of Pathology, Pusan National University Yangsan Hospital, Yangsan, Korea.
                [d ]Department of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
                Author notes
                Correspondence: Na-Yeon Jung, MD, PhD. Department of Neurology, Pusan National University Yangsan Hospital, Pusan National University School of Medicine and Research Institute for Convergence of Biomedical Science and Technology, 20 Geumo-ro, Mulgeum-eup, Yangsan 50612, Korea. Tel +82-55-360-2122, Fax +82-55-360-2152, nyjung@ 123456pusan.ac.kr
                Author information
                https://orcid.org/0000-0002-8265-9508
                https://orcid.org/0000-0002-2995-6060
                https://orcid.org/0000-0003-4998-1244
                https://orcid.org/0000-0001-9846-6500
                Article
                10.3988/jcn.2022.18.3.358
                9163938
                35589323
                501bfc21-2bfa-4716-b230-4bc663e10868
                Copyright © 2022 Korean Neurological Association

                This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

                History
                : 02 November 2021
                : 07 February 2022
                : 07 February 2022
                Funding
                Funded by: Pusan National University Yangsan Hospital;
                Award ID: 30-2017-006
                Categories
                Letter to the Editor

                Neurology
                Neurology

                Comments

                Comment on this article